Scancell Holdings plc
SCLP.L · LSE
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.10 | 0.25 | -0.07 | 0.75 |
| FCF Yield | -5.87% | -20.59% | -6.54% | -7.36% |
| EV / EBITDA | -8.16 | -11.61 | -10.43 | -25.02 |
| Quality | ||||
| ROIC | -96.76% | -61.07% | -34.43% | -28.71% |
| Gross Margin | 76.29% | 0.00% | 90.04% | 0.00% |
| Cash Conversion Ratio | 0.50 | 1.72 | 0.57 | 1.24 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.67% | – | – | – |
| Free Cash Flow Growth | 61.36% | -89.82% | 2.39% | -78.10% |
| Safety | ||||
| Net Debt / EBITDA | 0.05 | -0.71 | 0.03 | 5.91 |
| Interest Coverage | -8.74 | -16.77 | -9.81 | -4.95 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -9.37 |
| Cash Conversion Cycle | 288.99 | -552.03 | -613.90 | -1,093.03 |